Pharmaceutical: OTC Active Ingredients - Sourcing the Cold and Cough Shelf
Updated: 1 hour ago
Walk down any pharmacy aisle and the active ingredient labels repeat in patterns most consumers never notice. For the formulators behind those labels, supply for these molecules has gotten harder, not easier, over the last five years. Download our line cards here.
OTC Active Ingredients and the Sourcing Reality Since 2020
Guaifenesin, dextromethorphan, diphenhydramine, phenylephrine, and the chlorpheniramine and brompheniramine family form the backbone of nearly every OTC cold, cough, and allergy product on a U.S. shelf. They're commodity by category but specialty by execution — particle size, direct compression behavior, residual solvent profile, and lot-to-lot consistency all separate a quality supplier from a vendor moving boxes.
Tablets and capsules on red, titled The Cold and Cough Shelf OTC active ingredients guaifenesin, dextromethorphan, and diphenhydramine Capsules on red with text on how OTC active ingredient supply has changed since 2020
The category also rewards depth. Most OTC formulators don't want one supplier for guaifenesin and a different one for dextromethorphan. They want a single point of contact for the entire active list, with reliable inventory and documentation that arrives ahead of the order. Ampak supplies the full OTC active ingredients portfolio — actives and excipients — held in U.S. warehouses across multiple locations.
What's changed since 2020 is the supply chain itself. Lead times have stretched. Sourcing dynamics have shifted. The buyers who haven't repositioned their structure are exposed in ways that don't show up until a quarter goes sideways.
